Stay updated on Belantamab Mafodotin vs Pom/Dex in RRMM Clinical Trial

Sign up to get notified when there's something new on the Belantamab Mafodotin vs Pom/Dex in RRMM Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Belantamab Mafodotin vs Pom/Dex in RRMM Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The DREAMM-3 study locations were updated to add and remove sites, with the page now indicating 102 locations (including Omaha, NE and Shibuya-Ku, Tokyo) and a revision to version 3.4.2.
    Difference
    2%
    Check dated 2026-02-13T13:41:22.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    Revision tag updated from v3.4.0 to v3.4.1 is displayed. This appears to be a non-substantive UI/version update and does not modify study content or parameters.
    Difference
    0.0%
    Check dated 2026-02-05T23:48:43.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    31 days ago
    Change Detected
    Summary
    Added Revision: v3.3.4. Removed 'Multiple myeloma' and the related topic 'MedlinePlus Genetics', and removed Revision: v3.3.3.
    Difference
    0.1%
    Check dated 2026-01-15T04:22:36.000Z thumbnail image
  5. Check
    46 days ago
    Change Detected
    Summary
    The page now includes an additional topic tag for 'Multiple myeloma' and a related topic link to 'MedlinePlus Genetics'. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-31T15:18:29.000Z thumbnail image
  6. Check
    53 days ago
    Change Detected
    Summary
    Locations section updated with new regions (Arizona, Colorado, Michigan, New York, Ohio, Oregon, Texas, Wisconsin, New South Wales, South Australia, Tasmania, Victoria, Western Australia, Rio Grande do Sul, Alberta) and removal of the previous 'Locations' subheadings; Revision: v3.3.3 tag added.
    Difference
    0.8%
    Check dated 2025-12-24T14:25:14.000Z thumbnail image
  7. Check
    82 days ago
    Change Detected
    Summary
    Added mentions of Multiple Myeloma and related topics (MedlinePlus Genetics) and the revision note 'Revision: v3.3.2'. The PubMed publications boilerplate was revised with a note 'Revision: v3.2.0'.
    Difference
    0.1%
    Check dated 2025-11-25T13:59:55.000Z thumbnail image

Stay in the know with updates to Belantamab Mafodotin vs Pom/Dex in RRMM Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Belantamab Mafodotin vs Pom/Dex in RRMM Clinical Trial page.